(Q39804141)

14 September 2017

title

P53 and p38 MAPK pathways are involved in MONCPT-induced cell cycle G2/M arrest in human non-small cell lung cancer A549. (English)

1 reference

14 September 2017

Chong Zhang

1

1 reference

14 September 2017

Hong Zhu

2

1 reference

14 September 2017

Xiaochun Yang

3

1 reference

14 September 2017

Jianshu Lou

4

1 reference

14 September 2017

Difeng Zhu

5

1 reference

14 September 2017

Wei Lu

6

1 reference

14 September 2017

Qiaojun He

7

1 reference

14 September 2017

Bo Yang

8

1 reference

14 September 2017

publication date

2 September 2009

1 reference

Journal of Cancer Research and Clinical Oncology

14 September 2017

published in

1 reference

14 September 2017

volume

136

1 reference

14 September 2017

issue

3

1 reference

14 September 2017

page(s)

437-445

1 reference

https://scigraph.springernature.com/pub.10.1007/s00432-009-0674-5

14 September 2017

exact match

0 references

cites work

Induction of p53-dependent and p53-independent cellular responses by topoisomerase 1 inhibitors

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00432-009-0674-5

ArhGAP9, a novel MAP kinase docking protein, inhibits Erk and p38 activation through WW domain binding

21 January 2018

1 reference

12 December 2020

Myt1: a membrane-associated inhibitory kinase that phosphorylates Cdc2 on both threonine-14 and tyrosine-15.

1 reference

12 December 2020

Genistein at a concentration present in soy infant formula inhibits Caco-2BBe cell proliferation by causing G2/M cell cycle arrest

1 reference

12 December 2020

Equivalent effect of DNA damage-induced apoptotic cell death or long-term cell cycle arrest on colon carcinoma cell proliferation and tumour growth

1 reference

12 December 2020

Gambogic acid-induced G2/M phase cell-cycle arrest via disturbing CDK7-mediated phosphorylation of CDC2/p34 in human gastric carcinoma BGC-823 cells

1 reference

12 December 2020

Akt inhibits Myt1 in the signalling pathway that leads to meiotic G2/M-phase transition.

1 reference

12 December 2020

Plumbagin (5-hydroxy-2-methyl-1,4-naphthoquinone) induces apoptosis and cell cycle arrest in A549 cells through p53 accumulation via c-Jun NH2-terminal kinase-mediated phosphorylation at serine 15 in vitro and in vivo

1 reference

12 December 2020

p107wee1 is a dual-specificity kinase that phosphorylates p34cdc2 on tyrosine 15

1 reference

12 December 2020

Cellular effects of CPT-11 on colon carcinoma cells: dependence on p53 and hMLH1 status

1 reference

12 December 2020

Plant antitumor agents. 23. Synthesis and antileukemic activity of camptothecin analogues

1 reference

12 December 2020

Regulatory roles of cyclin dependent kinase phosphorylation in cell cycle control

1 reference

12 December 2020

1 reference

12 December 2020

Lower cyclin H and cyclin-dependent kinase-activating kinase activity in cell cycle arrest induced by lack of adhesion to substratum

1 reference

12 December 2020

Mitogen-activated protein kinase kinase activity is required for the G(2)/M transition of the cell cycle in mammalian fibroblasts

1 reference

12 December 2020

Asiatic acid, a triterpene, induces apoptosis and cell cycle arrest through activation of extracellular signal-regulated kinase and p38 mitogen-activated protein kinase pathways in human breast cancer cells.

1 reference

12 December 2020

Chk1 and Chk2 are differentially involved in homologous recombination repair and cell cycle arrest in response to DNA double-strand breaks induced by camptothecins

1 reference

12 December 2020

Potent antitumor activity of 10-methoxy-9-nitrocamptothecin

1 reference

12 December 2020

Plk1 promotes nuclear translocation of human Cdc25C during prophase

1 reference

12 December 2020

Transcriptional regulation of mitotic genes by camptothecin-induced DNA damage: microarray analysis of dose- and time-dependent effects.

1 reference

12 December 2020

Regulation of the G2/M transition by p53.

1 reference

12 December 2020

7- and 10-substituted camptothecins: dependence of topoisomerase I-DNA cleavable complex formation and stability on the 7- and 10-substituents

1 reference

12 December 2020

Cell cycle regulation by the Wee1 inhibitor PD0166285, pyrido [2,3-d] pyimidine, in the B16 mouse melanoma cell line

1 reference

12 December 2020

Licochalcone-A, a novel flavonoid isolated from licorice root (Glycyrrhiza glabra), causes G2 and late-G1 arrests in androgen-independent PC-3 prostate cancer cells

1 reference

12 December 2020

Anti-tumor effect of bisphosphonate (YM529) on non-small cell lung cancer cell lines

1 reference

12 December 2020

Silencing of polo-like kinase (Plk) 1 via siRNA causes induction of apoptosis and impairment of mitosis machinery in human prostate cancer cells: implications for the treatment of prostate cancer.

1 reference

12 December 2020

Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. Non-small Cell Lung Cancer Collaborative Group

1 reference

12 December 2020

Keratinocyte G2/M growth arrest by 1,25-dihydroxyvitamin D3 is caused by Cdc2 phosphorylation through Wee1 and Myt1 regulation.

1 reference

12 December 2020

Cell cycle. Confirmational change.

1 reference

12 December 2020

Distinct cell cycle timing requirements for extracellular signal-regulated kinase and phosphoinositide 3-kinase signaling pathways in somatic cell mitosis

1 reference

12 December 2020

SarCNU-induced G2/M arrest in hepatoma cells is mediated by a p53-independent phosphorylation of cdc-2 at Tyr15.

1 reference

12 December 2020

10.1007/S00432-009-0674-5

Identifiers

DOI

1 reference

14 September 2017

1 reference